Please assess the completion status of the following clinical trial:

Trial Title: Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Cervical dystonia with at least 18 months since onset, and previously untreated with botulinum toxin or previously treated with botulinum toxin type A or B with a minimum interval of 16 weeks since the last injection and having returned at least to their usual pre-treatment status~* TWSTRS severity, disability and total scores meeting the defined criteria at baseline~Exclusion Criteria:~* Pure anterocollis or pure retrocollis~* In apparent remission from cervical dystonia~* Previous poor response to the last two botulinum toxin type A or type B treatments~* Being treated with type B toxin due to lack of efficacy to type A toxin or have known neutralizing antibodies to type A toxin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Drug: abobotulinumtoxinA (Dysport®)
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).